微创泪道再通联合置管治疗泪道阻塞

摘要

Objective To explore the clinical effect of lacrimal endoscope assisted minimally invasive lacrimal duct recanalization combined with silicone tube intubation in the treatment of lacrimal duct obstruction. Methods 3 cases(4 eyes)of the superior canaliculus obstruction,5 cases(6 eyes)of the inferior canaliculus,20 cases (29 eyes) of common canaliculus and 25 cases (36 eyes) of nasolacrimal duct were enrolled. They were randomly divided into two groups:Group A(40 eyes)treated with lacrimal endoscope assisted laser lacrimal forming combined with silicone tube implantation and Group B(36 eyes)with lacrimal endoscope assisted laser lacrimal forming combined with silicone tube implantation. The cases were all followed up for 3-6 months after treatment. Results Except the intraoperative bleeding,there were no significant differences in the incidence of various complications. All the eyes could be recanalized under the aid of lacrimal endoscope. The total effective rates were 87.50% and 91.43% in Group A and B,respectively. The difference was not statistically significant. Conclusion Lacrimal endoscope assisted minimally invasive lacrimal duct recanalization combined with silicone tube intubation is a safe,effective,and minimally invasive method to recanalize the lacrimal obstruction.%目的 探讨泪道内窥镜辅助下的微创泪道再通联合硅胶管植入术治疗泪道阻塞的临床疗效.方法 收集上泪小管阻塞3例4眼、下泪小阻塞5例6眼,泪总管阻塞20例29眼,鼻泪管阻塞25例36眼.随机分为两组,分别是泪道内窥镜辅助下的激光泪道成形联合泪道置管组(A组40只眼)、泪道内窥镜辅助下的微钻成形联合泪道置管组(B组35只眼).治疗后随访3~6个月.结果 除术中出血外,两种手术方式各种并发症的发生率未见明显区别.A组患者泪道再通总有效率达到87.50%;B组患者泪道再通总有效率达到91.43%,差异没有统计学意义.结论 泪道内窥镜辅助下的微创泪道再通联合硅胶管植入治疗泪道阻塞是一种安全、有效的方法,损伤小,恢复快,并发症少.